Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Teleflex (TFX)
TipRanks (Mon, 10-Aug 8:00 AM ET)
Teleflex Announces Quarterly Dividend
Business Wire (Thu, 6-Aug 6:45 AM ET)
Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook
Business Wire (Thu, 6-Aug 6:30 AM ET)
Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow's MedTech Innovators
Globe Newswire (Tue, 4-Aug 8:00 AM ET)
Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion
Business Wire (Mon, 3-Aug 4:15 PM ET)
Teleflex Announces FDA BLA Approval of EZPLAZ Freeze Dried Plasma
Business Wire (Wed, 29-Jul 4:15 PM ET)
Teleflex Announces Second Quarter 2026 Earnings Conference Call Information
Business Wire (Thu, 23-Jul 6:30 AM ET)
Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.
Business Wire (Tue, 21-Jul 8:44 AM ET)
Teleflex Publishes 2025 Global Impact Report
Business Wire (Tue, 7-Jul 6:30 AM ET)
Business Wire (Tue, 23-Jun 6:30 AM ET)
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Teleflex trades on the NYSE stock market under the symbol TFX.
As of August 13, 2026, TFX stock price declined to $135.46 with 213,196 million shares trading.
TFX has a beta of 0.95, meaning it tends to be less sensitive to market movements. TFX has a correlation of 0.09 to the broad based SPY ETF.
TFX has a market cap of $5.74 billion. This is considered a Mid Cap stock.
Last quarter Teleflex reported $570 million in Revenue and $1.76 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.49.
In the last 3 years, TFX traded as high as $257.85 and as low as $100.18.
The top ETF exchange traded funds that TFX belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.
TFX has underperformed the market in the last year with a price return of +14.4% while the SPY ETF gained +22.1%. TFX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +5.2% and +0.6%, respectively, while the SPY returned +5.6% and +6.6%, respectively.
TFX support price is $133.38 and resistance is $139.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.